Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The Oxford University and AstraZeneca vaccine trials reached 90% efficacy by accident thanks to the “serendipity” of an error that led to some participants receiving half doses, it has emerged.
On Monday scientists revealed that the Oxford vaccine had an overall efficacy of 70%, but could be around 90% effective when administered as a half dose followed by a full dose a month later.
“The reason we had the half dose is serendipity,” said Mene Pangalos, executive vice-president of biopharmaceuticals research and development at AstraZeneca.
When university researchers were distributing the vaccine at the end of April, around the start of Oxford and AstraZeneca’s partnership, they noticed expected side effects such as fatigue, headaches or arm aches were milder than expected.
“So we went back and checked … and we found out that they had underpredicted the dose of the vaccine by half,” said Pangalos.
😱 🙂
On Monday scientists revealed that the Oxford vaccine had an overall efficacy of 70%, but could be around 90% effective when administered as a half dose followed by a full dose a month later.
“The reason we had the half dose is serendipity,” said Mene Pangalos, executive vice-president of biopharmaceuticals research and development at AstraZeneca.
When university researchers were distributing the vaccine at the end of April, around the start of Oxford and AstraZeneca’s partnership, they noticed expected side effects such as fatigue, headaches or arm aches were milder than expected.
“So we went back and checked … and we found out that they had underpredicted the dose of the vaccine by half,” said Pangalos.
Oxford Covid vaccine hit 90% success rate thanks to dosing error
Participants given first shot at half strength by mistake were found to be better protected
www.theguardian.com
😱 🙂